Avricore Health Inc
TSXV:AVCRView on OTCQB

  • LAST PRICE
    0.1550
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.1550/ 119
  • Ask / Lots
    0.1600/ 34
  • Open / Previous Close
    0.0000 / 0.1550
  • Day Range
    ---
  • 52 Week Range
    0.1050
    0.2950
  • Volume
    175

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Apr 30, 2024

      Show headlines and story abstract

    • 6:00AM ET on Tuesday Apr 30, 2024 by GlobeNewswire
      Companies Mentioned: AVCRF

    • 6:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
      Companies Mentioned: AVCR

      The Company incurred a comprehensive loss of $661,066 for the twelve months ended December 31, 2023 (2022 - $818,228). Significant changes are as follows:
      -- Revenue increased to $3,485,147 (2022 - $1,768,374) a 97% increase due to an increase in HealthTab(TM) systems deployed and tests sold. Gross profit amounted to $1,203,396 (2022 -- $456,793) a 163% increase. Gross margin for the period was 35% (2022- 26%) outperforming the Company's target margin of 30%. -- Share-based compensation of $703,612 (2022 - $331,522) was recognized for stock options granted, vested, and repriced during the period. -- Consulting fees increased to $236,117 (2022 - $197,860) primarily due to an increase in fees payable to the CTO. -- General and administrative expenses increased to $339,369 (2022 - $250,144) mainly due to increase in operations as compared with previous period. -- Management fees increased to $216,000 (2022 - $168,000) due to an increase in fees payable to the CEO. -- Professional fees increased to $285,935 (2022 -- 150,585) mainly due to an increase in audit fees.

Peers Headlines